Gene Expression Can Predict the Survival of Lymphoma Patients

ResearchBlogging.orgA study published last week in the New England Journal of Medicine identified sets of genes in diffuse large B-cell lymphoma that influence the effectiveness of chemotherapy [1]. Researchers found that the tumor microenvironment, consisting of non-cancerous immune and structural cells along with tumor cells, has a significant influence on a patient’s response to treatment.

Treating Cancer with Personalized Medicine

A Michigan oncologist recently devised a simple experiment to help treat seven patients with advanced, incurable cancer. The experiment used DNA microarray technology to analyze each patient’s tumors for the expression of genes associated with positive response to anti-cancer drugs. The oncologist, Dr. Eric Lester, M.D., then based his drug treatment plans on the results. Four of seven patients are reported to have had a better outcome than expected [1].

microarrayAlthough every cell in the body contains identical genetic material, the same genes are not active in every cell. Tumor cells are no exception. Cancer refers to any one of a large number of diseases characterized by abnormal cell growth and proliferation. Few of these diseases can be treated in the same way, since the genes responsible for a variety of biological processes — DNA duplication, cellular proliferation, cell death — are different from one tumor to the next.